Hui Xin Ong

In vitro interactions of aerosol formulations with human nasal epithelium using real-time monitoring of drug transport in a nasal mucosa-on-a-chip

Real-time quantitative monitoring of <i>in vitro</i> nasal drug delivery by a nasal epithelial mucosa-on-a-chip model

Development and in vitro characterization of a novel pMDI diclofenac formulation as an inhalable anti-inflammatory therapy for cystic fibrosis

A Review of Respiratory Anatomical Development, Air Flow Characterization and Particle Deposition

Modifying and Integrating in vitro and ex vivo Respiratory Models for Inhalation Drug Screening

Smart thermosensitive chitosan hydrogel for nasal delivery of ibuprofen to treat neurological disorders

Application of a Thermosensitive In Situ Gel of Chitosan-Based Nasal Spray Loaded with Tranexamic Acid for Localised Treatment of Nasal Wounds

Co-Spray-Dried Urea Cross-Linked Hyaluronic Acid and Sodium Ascorbyl Phosphate as Novel Inhalable Dry Powder Formulation

In vitro characterization of physico-chemical properties, cytotoxicity, bioactivity of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate nasal powder formulation

Simvastatin Nanoparticles Reduce Inflammation in LPS-Stimulated Alveolar Macrophages

Combination of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate for the treatment of inflammatory lung diseases: An in vitro study

Sweetening Inhaled Antibiotic Treatment for Eradication of Chronic Respiratory Biofilm Infection

Inhaled Simvastatin Nanoparticles for Inflammatory Lung Disease

Novel nano-cellulose excipient for generating non-Newtonian droplets for targeted nasal drug delivery

Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products

Primary Air–Liquid Interface Culture of Nasal Epithelium for Nasal Drug Delivery

Is the cellular uptake of respiratory aerosols delivered from different devices equivalent?

Across the pulmonary epithelial barrier: Integration of physicochemical properties and human cell models to study pulmonary drug formulations

Combined Inhaled Salbutamol and Mannitol Therapy for Mucus Hyper-secretion in Pulmonary Diseases

Pharmaceutical applications of the Calu-3 lung epithelia cell line

In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation

Ciprofloxacin Is Actively Transported across Bronchial Lung Epithelial Cells Using a Calu-3 Air Interface Cell Model

Liposomal Nanoparticles Control the Uptake of Ciprofloxacin Across Respiratory Epithelia